Home › Executives › Pandurang Kulkarni. PhD
Pandurang Kulkarni. PhD

Pandurang Kulkarni. PhD

CEO of Aparito (wholly owned subsidiary of Eli Lilly), Board of Director for CDISC at CDISC

Eli Lilly and Company•Indianapolis, Indiana, United States

View LinkedIn Profile
Experience25+ Years
LevelLeadership

Career Timeline

Professional employment history
  • Eli Lilly and CompanyCurrent
    Dec 2000–Present· 25 yrs 10 mos
    • Chief Executive Officer, Aparito, Chief Analytics Officer, Research and Development, Senior Vice President, Statistics, Data, and AnalyticsCurrent
      Nov 2024–Present
    • Sr Vice President Global Data Sciences and Lilly Research Laboratory Development Global Centers.
      Jun 2022–Nov 2024
    • Chief Analytics Officer R&D, VP Biometrics
      Jun 2016–Jun 2022
    • Vice President of Biometrics and Advanced Analytics
      Oct 2013–Jun 2022
    • Senior Director of Global Oncology Statistics (Phase I-IV)
      Sep 2009–Oct 2013
    • Senior Director of Medical Info Sciences (Medical Liaisons, Med Info, Med Writing, Stats, programmin
      Oct 2007–Sep 2009
    • Various (Leading statistics and other functions)
      Dec 2000–Sep 2007

Education

PhD

Statistics

La Trobe University

Executive Relationship Map

Reports To
Pandurang Kulkarni. PhD
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer

Executive Network Preview

BizKonnect has mapped this leadership network including reporting hierarchies, peer connections, and cross-functional relationships.

Verified Contact Information
Email & Direct Dial
Org Chart & Reporting Lines
Buying Committee Insights
AI-Powered Account Mapping

Skills & Expertise

20 of 20 skills
Regulatory SubmissionsDrug DiscoveryBiostatisticsOncologyClinical Study DesignClinical ResearchDiabetesClinical Data ManagementMedical WritingDrug DevelopmentPharmacovigilanceGCPClinical DevelopmentClinical TrialsCROTherapeutic AreasCDISCPharmaceutical IndustryBiotechnologyCancer